CEO: | Anders Lundstrom |
Independent Non-Executive Director: | Fabiana Lacerca Allen |
Independent Non-Executive Director: | Peter Llewellyn-Davies |
Non-Executive Chairman: | Hans-Peter Hasler |
Non-Executive Dir: | Christian Schweiger |
Address: | Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF |
Phone: | +44 (0) 191 511 8500 |
Website: | http://www.shieldtherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYV81293 |
Currency | UK Pounds |
Share Price | 8.15p |
Change Today | -0.100p |
% Change | -1.21 % |
52 Week High | 9.00 |
52 Week Low | 2.25 |
Volume | 1,447,805 |
Shares Issued | 1,061.80m |
Market Cap | £86.54m |
Beta | 0.03 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:09 | 75,625 @ 8.03p |
15:15 | 5,000 @ 8.27p |
15:10 | 320 @ 8.30p |
15:07 | 5,000 @ 8.30p |
15:07 | 5,000 @ 8.30p |
You are here: research